1. Home
  2. |Insights
  3. |GAO And SBA Disagree on Effect of Noncompliance With Subcontracting Limitation

GAO And SBA Disagree on Effect of Noncompliance With Subcontracting Limitation

Client Alert | 1 min read | 04.10.07

In TYBRIN Corp. (Mar. 13, 2007, http://www.gao.gov/decisions/bidpro/2983646.pdf), GAO sustained a protest of the Air Force's reinstatement of a contract award despite the Air Force's reliance on and compliance with the SBA's responsibility determination in favor of the awardee (which was based on the SBA's finding that the awardee, despite having not committed to do so in its proposal, would in fact comply with the RFP's limitation on the extent of subcontracting to large businesses). Despite the SBA's conclusion to the contrary, and the Air Force's reliance on that conclusion, GAO held that where an offeror's proposal fails to comply with a material terms of the solicitation (in this case, the limitation on subcontracting clause as set forth in FAR 52.219-14), the matter is one of the proposal's acceptability or responsiveness (which is reviewable by GAO) rather than the offeror's responsibility (which is solely within the purview of the SBA, if it involves a small business).

Insights

Client Alert | 2 min read | 09.18.25

FDA Announces Intention to Initiate an Aggressive Enforcement Campaign Against Misleading Pharmaceutical Advertising

On September 9, 2025, the U.S. Department of Health and Human Services (HHS) and the Food and Drug Administration (HHS) issued a news release announcing an “aggressive[]” “crackdown” on direct-to-consumer pharmaceutical advertising. This release came on the heels of a Presidential Memorandum President Trump issued the same day directing HHS to “ensure transparency and accuracy in direct-to-consumer prescription drug advertisements,” and the FDA to “take action to enforce legal requirements that advertisements for prescription drugs be truthful and not misleading.”...